Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk

OBJECTIVES: Cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) often coexist. We assessed the effect of inhaled COPD treatments on CVD outcomes and safety in patients with COPD and at heightened CVD risk. METHODS: The SUMMIT (Study to Understand Mortality and MorbidITy) wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Brook, Robert D, Anderson, Julie A, Calverley, Peter MA, Celli, Bartolome R, Crim, Courtney, Denvir, Martin A, Magder, Sheldon, Martinez, Fernando J, Rajagopalan, Sanjay, Vestbo, Jørgen, Yates, Julie, Newby, David E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Heart 2017
Materias:
Pulmonary Vascular Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629944/
https://www.ncbi.nlm.nih.gov/pubmed/28416587
http://dx.doi.org/10.1136/heartjnl-2016-310897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629944/
https://www.ncbi.nlm.nih.gov/pubmed/28416587
http://dx.doi.org/10.1136/heartjnl-2016-310897

Ejemplares similares